Key Players in Motion Sickness Drugs Market Include GlaxoSmithKline, Novartis, and Teva Pharmaceuticals

DUBLIN, Oct. 26, 2023 /PRNewswire/ — The “Global Motion Sickness Drugs Market 2023-2027” report has been added to ResearchAndMarkets.com’s offering. The global motion sickness drugs market is poised for substantial growth, with a projected increase of USD 136.49 million during the period…